Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
01/2000
01/13/2000WO2000001650A1 Method of vitamin production
01/13/2000WO2000001649A1 Method of vitamin production
01/13/2000DE19830431A1 Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators
01/13/2000CA2831321A1 Production of isoprenoid in recombinant yeast
01/13/2000CA2336904A1 Novel fluorescent lanthanide chelates
01/13/2000CA2332308A1 Method of vitamin production
01/13/2000CA2331343A1 Production of isoprenoid in recombinant yeast
01/12/2000EP0970953A1 Manufacture of d,1-alpha-tocopherol
01/12/2000EP0969822A2 Compositions and methods for restoring a normal pattern of imprinting to cells
01/12/2000CN1241170A 2-adamantyl benzopyrans, composition and (co)polymer matrixes contg. them
01/12/2000CN1048244C Method for preparing 4-hydroxy coumarin
01/11/2000US6013809 Analgesics
01/10/2000CA2276921A1 Manufacture of d,1-alpha-tocopherol
01/06/2000WO2000000489A2 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
01/06/2000WO2000000484A1 Substituted benzopyran derivatives and their use as anticonvulsants
01/06/2000CA2336089A1 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
01/06/2000CA2335846A1 Substituted benzopyran derivatives and their use as anticonvulsants
01/05/2000EP0968203A1 Photoactive coumarin sulfonate compounds
01/05/2000EP0968202A1 Process for preparing photoactive coumarin derivatives
01/05/2000EP0968201A2 New aminopiperazine derivatives
01/05/2000EP0968181A1 Perfluorynated sulphone salts, and their uses as ionic conduction materials
01/05/2000CN1240418A Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds
01/04/2000US6011059 Acyl guanidine sodium/proton exchange inhibitors and method
01/04/2000US6011058 Cdc25 phosphatase inhibition properties and anti-cancer activity.
01/04/2000US6011057 Methods for inhibiting uterine fibroid disease
01/04/2000US6011024 Steroid sulphatase inhibitors
12/1999
12/29/1999WO1999067234A1 Photochromic naphthopyrans
12/29/1999WO1999067201A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
12/29/1999WO1999067192A2 PROCESS FOR THE SOLID PHASE SYNTHESIS OF ALDEHYDE, KETONE, OXIME, AMINE, HYDROXAMIC ACID AND α,β-UNSATURATED CARBOXYLIC ACID AND ALDEHYDE COMPOUNDS
12/29/1999EP0966684A1 Compounds for detecting phosphoric acid esters
12/29/1999EP0966458A1 Sulfonated xanthene derivatives
12/29/1999EP0966420A1 2-arylcyclopentan-1,3-diones
12/29/1999EP0906366A4 Novel photochromic indeno-fused naphthopyrans
12/29/1999CN1239941A Aryl or heteroaryl substd. 3, 4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo [1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs.
12/29/1999CN1239886A Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agent
12/29/1999CA2335513A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
12/29/1999CA2335511A1 Process for the synthesis of .alpha.,.beta. alkenoate resin compounds
12/28/1999US6008383 Method of preparing delta-9-tetrahydrocannabinol esters
12/28/1999US6008381 Process for preparing 3-isochromanone
12/28/1999US6008379 Useful as fluorescent dyes for labeling
12/28/1999US6008245 Treatment of prophylaxis and cardiovascular disorders, in particular arrhythmias, for the treatment of ulcers of the gastrointestinal disorders, diarrheal diseases
12/28/1999US6008242 Administering 1-3,4-trans-2,2-dimethy-3-phenyl-4-(4-(2-(pyrrolidin-1-yl)etho xy)phenyl)-7-methoxychroman
12/28/1999US6008219 Bicyclic amine derivatives and their use as anti-psychotic agents
12/28/1999US6008204 Antidotes for preventing certain undesired side effects of retinoids
12/28/1999US6008008 Esculetin derivatives
12/23/1999WO1999066062A1 Biocatalytic process for the preparation of 3-0-acyl-flavonoids
12/23/1999WO1999065893A1 Novel benzopyran or thiobenzopyran derivatives
12/23/1999CA2334634A1 Novel benzopyran or thiobenzopyran derivatives
12/22/1999EP0965344A1 Prophylactic and therapeutic agent for inflammatory intestinal diseases
12/22/1999EP0964683A1 Leukotriene antagonists for oral squamous cell carcinoma
12/22/1999CN1239477A Process for crystallizing d-alpha-tocopheryl succinate
12/21/1999US6005122 Preparation of α-tocopherol or α-tocopheryl acetate by reacting trimethylhydroquinone and phytol or isophytol, with recycling of the zinc halide condensation catalyst
12/21/1999US6005093 Conmpounds used as replacements for one or more complementary nucleoside bases in probes; enable photoactive crosslinking of nucleic acid strands in hybridization assays and therapeutic applications
12/21/1999US6005003 Osteoporosis treatment
12/21/1999US6004998 Flavonoid 6,8-dibromochrysin
12/21/1999US6004978 Methods of treating cancer with aromatic nitro and nitroso compounds and their metabolites
12/21/1999US6004971 Pentacyclic compounds, intermediates, processes, compositions, and methods
12/21/1999CA2035653C Neuroprotective 3-piperidino-4-hydrosychroman derivatives
12/16/1999WO1999064408A1 Prodrugs of estrogen antagonist
12/16/1999WO1999064379A2 Biomimetic combinatorial synthesis
12/16/1999WO1999063995A1 Isoflavone derivatives
12/16/1999WO1999063974A2 Selective estrogen receptor modulator in combination with denydroepiandrosterone (dhea) or analogues
12/16/1999CA2768882A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768841A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768828A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768773A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768682A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/15/1999EP0963755A2 Use of benzopyranes for preventing allograft rejection
12/15/1999EP0767780B1 Amino acid derivatives and their use as pesticides
12/15/1999EP0642504B1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
12/15/1999CN1238768A Process for preparing tolterodine
12/15/1999CN1047403C Process for the preparation of large ring lactone antibiotic
12/15/1999CN1047307C Application of aucubine for the treatment of hepatitis B virus (HBV) infection
12/14/1999US6002020 Process for the catalytic preparation of 3-isochromanones from phthalans
12/14/1999US6001998 Macrocyclic lactone compounds and their production process
12/14/1999US6001393 Ginkgo biloba extract enhanced bioavailability composition and food products
12/14/1999CA2017767C Anticancer antibiotic mi43-37f11 substance, the production and uses thereof
12/14/1999CA2014971C Inhibitive agent against activity of alpha-amylase
12/14/1999CA2014555C Preventive and curative medicament against infection with influeza virus
12/09/1999WO1999063108A1 Novel peroxidase substrates and their use in catalyzed reporter deposition
12/09/1999WO1999062896A1 Novel polyoxypropylenepolyoxyethylene vitamin e and preparation thereof
12/09/1999WO1999043285A3 Sulphonamide derivatives
12/09/1999DE19824535A1 Neue Rhodamin-Derivate und deren Verwendung New rhodamine derivatives and their use
12/08/1999EP0962497A1 Rhodamine derivates and their use in diagnostic systems
12/08/1999EP0961617A1 Leukotriene antagonists for cerebral focal stroke
12/08/1999EP0961615A1 Antimicrobial agent
12/08/1999EP0771196B1 Excitatory amino acid receptor antagonists
12/08/1999EP0702952B1 Benzopyran derivatives
12/08/1999EP0678086B1 Compounds having selectivity for retinoid x receptors
12/08/1999CN1237961A Aminoguanidines and alkoxyguanidines as protease inhibitors
12/07/1999US5998593 Fluorescent enzyme substrates
12/07/1999US5998496 Photosensitive intramolecular electron transfer compounds
12/07/1999US5998465 Reduce tissue damage; antiinflammatory agents; oxidation resistance
12/07/1999US5998464 4-Oxa and 4-thia steroids
12/07/1999US5998461 Sleep disorders
12/07/1999US5998451 Lipoxygenase inhibitors
12/02/1999DE19913687A1 New photochromic diarylnaphthopyrans useful in plastics, especially for ophthalmic purposes
12/02/1999DE19902771A1 Photochromic spiro-fluoreno-pyran compounds, useful in plastic optical components, e.g. lenses, spectacle glasses, windows, blinds, covers, roofing etc.
12/01/1999EP0960109A1 Process to prepare tolterodine
12/01/1999EP0960108A1 Matrix metalloproteinase inhibitors